Desmopressin ( DrugBank: Desmopressin )

5 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2
64	血栓性血小板減少性紫斑病	1
72	下垂体性ADH分泌異常症	1
225	先天性腎性尿崩症	1
288	自己免疫性後天性凝固因子欠乏症	6

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00806468 (ClinicalTrials.gov)	February 2009	9/12/2008	Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease	A Double Blind, Placebo Controlled, Randomized, Monocentre Cross-over Study to Investigate the Effec ...	Parkinson Disease	Drug: Desmotabs	Johannes Gutenberg University Mainz	NULL	Terminated	18 Years	85 Years	Male	1	Phase 4	Germany
2	EUCTR2008-003966-25-DE (EUCTR)	23/12/2008	04/11/2008	Double-blind, placebo controlled, randomised, monocenter cross-over studie to evaluate the effect of ...	Double-blind, placebo controlled, randomised, monocenter cross-over studie to evaluate the effect of ...	Effect of Desmopressinon the nocturnal polyuria in patients with idiopathic Parkinson Syndrome MedDR ...	Trade Name: Desmotabs® 0,2 mg Tabletten Product Name: Desmotabs® 0,2mg Tabletten INN or Proposed INN: ...	Universität Mainz, Klinik und Poliklinik für Neurologie	NULL	Not Recruiting			Female: no Male: yes	20		Germany

First Previous1Next Last

64. 血栓性血小板減少性紫斑病

臨床試験数 : 92 / 薬物数 : 85 - (DrugBank : 21) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 76

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2007-004371-19-AT (EUCTR)	20/11/2007	12/12/2007	A Phase 2 Pilot Study of the Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 Injection in ...	A Phase 2 Pilot Study of the Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 Injection in ...	von Willebrand Factor- related platelet function disorders : thrombotic thrombocytopenic purpura(TTP ...	Product Name: ARC1779 Injection Product Code: ARC1779 Other descriptive name: ARC 1779 Trade Name: Octo ...	Archemix Corp.	NULL	Not Recruiting			Female: yes Male: yes	28	Phase 2	Austria

First Previous1Next Last

72. 下垂体性ADH分泌異常症

臨床試験数 : 41 / 薬物数 : 27 - (DrugBank : 8) / 標的遺伝子数 : 7 - 標的パスウェイ数 : 10

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01280188 (ClinicalTrials.gov)	January 2011	19/1/2011	A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).	Peroral Administration of Different Doses of DesmopressinAdministered as a New Orally-Disintegrating ...	Central Diabetes Insipidus	Drug: Desmopressin Oral Melt;Drug: Desmopressin intranasal	Ferring Pharmaceuticals	NULL	Completed	6 Years	75 Years	Both	20	Phase 3	Japan

First Previous1Next Last

225. 先天性腎性尿崩症

臨床試験数 : 15 / 薬物数 : 48 - (DrugBank : 18) / 標的遺伝子数 : 31 - 標的パスウェイ数 : 65

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2012-001809-24-NL (EUCTR)	31/07/2013	06/09/2012	A diminished concentrating ability of the kidneys due to lithium prescription: how many and whom is ...	Evaluation of urinary concentrating defects in lithium treated patients with a dDAVP test - Nephroge ...	lithium-induced urinary concentrating defects (nephrogenic diabetes insipidus) MedDRA version: 15.0; ...	Trade Name: Desmopressine nasal spray 10 mg/ml, flacon 60 doses Product Name: Desmopressine nasal spr ...	Radboud University Nijmegen Medical Centre	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Netherlands

First Previous1Next Last

288. 自己免疫性後天性凝固因子欠乏症

臨床試験数 : 206 / 薬物数 : 231 - (DrugBank : 28) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 21

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-001631-46-NL (EUCTR)	14/02/2019	13/02/2019	Effects of pharmacokinetic models in dosing of DDAVP and/or von Willebrand factor-containing concent ...	Implementation of pharmacokinetic-guided dosing of DDAVP and VWF-containing concentrates in von Will ...	Von Willebrand disease MedDRA version: 20.0;Level: LLT;Classification code 10055168;Term: Von Willeb ...	Trade Name: Minrin INN or Proposed INN: DESMOPRESSIN Trade Name: Octostim INN or Proposed INN: DESMOPRE ...	Erasmus University Medical Center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 4	Netherlands
2	EUCTR2009-017060-17-NL (EUCTR)	10/12/2009	05/11/2009	STIMULATE study: Statins influence on Minrin upregulation of von Willebrand factor and factor VIII - ...	STIMULATE study: Statins influence on Minrin upregulation of von Willebrand factor and factor VIII - ...	Type 1 von Willebrand disease and mild hemophilia A	Trade Name: simvastatine Product Name: simvastatin INN or Proposed INN: SIMVASTATIN Trade Name: Minrin P ...	Academic Medical Center	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes			Netherlands
3	NCT01994330 (ClinicalTrials.gov)	June 2009	14/11/2013	Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressinin Valve-Rep ...	Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressinin Valve-Rep ...	Acquired Von Willebrand Disease Secondary to Severe Aortic Stenosis;Heye´s Syndrome;Severe Aortic St ...	Drug: desmopressin	Pontificia Universidad Catolica de Chile	Ferring Pharmaceuticals	Completed	N/A	N/A	All	13	Phase 4	Chile
4	EUCTR2007-004371-19-AT (EUCTR)	20/11/2007	12/12/2007	A Phase 2 Pilot Study of the Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 Injection in ...	A Phase 2 Pilot Study of the Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 Injection in ...	von Willebrand Factor- related platelet function disorders : thrombotic thrombocytopenic purpura(TTP ...	Product Name: ARC1779 Injection Product Code: ARC1779 Other descriptive name: ARC 1779 Trade Name: Octo ...	Archemix Corp.	NULL	Not Recruiting			Female: yes Male: yes	28	Phase 2	Austria
5	EUCTR2005-004496-38-DK (EUCTR)	22/06/2006	09/05/2006	Desmopressin in the management of von Willebrand disease; Biological versus clinical efficacy.	Desmopressin in the management of von Willebrand disease; Biological versus clinical efficacy.	von Willebrand disease (VWD) is an inherited bleeding disorder, characterised mainly by mucosal blee ...	Trade Name: Octostim Product Name: Octostim Product Code: DDAVP (Desmopressin) Trade Name: Octostim Prod ...	Rigshospitalet, Copenhagen	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 4	Denmark
6	NCT00111215 (ClinicalTrials.gov)	January 2001	18/5/2005	Treatment and Management of Women With Bleeding Disorders	Treatment and Management of Women With Bleeding Disorders	Menorrhagia;Blood Coagulation Disorders;Blood Platelet Disorders;Von Willebrand Disease;Hematologic ...	Drug: Tranexamic Acid;Drug: Desmopressin Acetate	Centers for Disease Control and Prevention	NULL	Completed	18 Years	50 Years	Female	100	N/A	United States

First Previous1Next Last

先頭へ